Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Multiple Myeloma

Drugs for Multiple Myeloma
Find financial assistance programs available for multiple myeloma drugs. Read More ›

Tecvayli Received FDA Approval for Patients with Relapsed or Refractory Multiple Myeloma

Thank You CONQUER Magazine for a Great Article
Sally K. Koski, PhD, RN, expresses her gratitude to CONQUER magazine for the very informative article, “Multiple Myeloma: Navigating the First 90 Days,” which was featured in the April 2022 issue. Read More ›

Living My Life While Dealing with Multiple Myeloma
Thomas Goode always worked out; when he felt an excruciating pain on his left side one day working out, he knew something was wrong and visited a surgeon. After terrible back pain months later and another x-ray and MRI, he was diagnosed with multiple myeloma. Read More ›

Targeting a Better Future for Patients with Multiple Myeloma
Christopher Greklek competed in Ironman races and was shocked when he was diagnosed with multiple myeloma. He describes being in and out of remission repeatedly, citing a program seeking to improve patient options. Read More ›

Contact a Myeloma Coach Through the Myeloma Crowd
Sally Torgeson explains how a myeloma coach can help newly diagnosed patients with the vast array of information, emotional, and financial demands of this type of blood cancer. Read More ›

Risk Status in Multiple Myeloma: Personalizing Your Care
Web Exclusives — May 19, 2022
Multiple myeloma is a relatively rare form of blood cancer that affects plasma cells, which are immune cells that produce antibodies. Read More ›

Carvykti Second CAR T-Cell Therapy FDA Approved for Patients with Multiple Myeloma

Multiple Myeloma: Navigating the First 90 Days
April 2022 Vol 8 No 2 — April 15, 2022
Nurse navigator and multiple myeloma expert Peg Rummel outlines the steps of dealing with multiple myeloma, including diagnostics, treatment planning, and barriers to care. Read More ›


Page 1 of 10